Study on the Impact of the 2014 ILAE Epilepsy Definition on Diagnosis, Patient Satisfaction, Cognition, and Economic Outcomes After a First Seizure

What this Trial Is About

Researchers are studying the effects of new diagnostic criteria for epilepsy introduced in 2014 by the International League Against Epilepsy. This study focuses on adults who have experienced their first epileptic seizure, examining how these updated criteria influence seizure frequency, medication adherence, quality of life, and cognitive performance over time. The study also explores potential changes in epilepsy incidence and severity due to improved early diagnosis and treatment methods, including enhanced imaging techniques. This observational study follows participants after their initial seizure, using questionnaires and neuropsychological tests to assess cognitive deficits and socio-economic impacts. It tracks outcomes such as employment status, salary, driving restrictions, and various cognitive tests over a ten-year period. The study aims to understand the health economic and neuropsychological consequences of early-stage epilepsy and the new diagnostic approach. Participants will undergo regular evaluations including neuropsychological testing and questionnaires to monitor cognitive abilities, quality of life, and social outcomes. The primary outcome is the rate of seizure recurrence over ten years, with secondary outcomes covering employment, salary, driving restrictions, and multiple cognitive assessments. The study is conducted at a single center and monitors participants health and social factors longitudinally to capture the full impact of the new epilepsy criteria.

Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure